Endometrial Hyperplasia and Epithelial Cytoplasmic Change

  • Michael T. Mazur
  • Robert J. Kurman

Abstract

Endometrial hyperplasia is a nonphysiologic, noninvasive proliferation of the endometrium that results in a morphologic pattern of glands with irregular shapes and varying size.1–6 This disorder results from sustained, unopposed estrogen stimulation and presents clinically as abnormal uterine bleeding. Sometimes hyperplasia is encountered incidentally in biopsies done for other reasons, such as an infertility workup or prior to or during hormone replacement therapy. Hyperplasia can mimic a wide variety of normal physiologic changes, artifacts resulting from tissue sampling and processing, benign organic disorders, and well-differentiated adenocarcinoma. Since management of these conditions and the different forms of hyperplasia can range from no treatment to hysterectomy, correct diagnosis is essential.

Keywords

Ciliated Cell Endometrial Hyperplasia Squamous Metaplasia Atypical Hyperplasia Cytologic Atypia 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Kurman RJ, Norris HJ: Endometrial hyperplasia and related cellular changes. In: Blaustein’s Pathology of the Female Genital Tract. 4th ed. Kurman RJ, ed. New York: Springer-Verlag, 1994; 411–437.CrossRefGoogle Scholar
  2. 2.
    Norris HJ, Tavassoli FA, Kurman RJ: Endometrial hyperplasia and carcinoma. Diagnostic considerations. Am J Surg Pathol 1983;7:839–847.PubMedGoogle Scholar
  3. 3.
    Silverberg SG: Hyperplasia and carcinoma of the endometrium. Semin Diagn Pathol 1988;5:135–153.PubMedGoogle Scholar
  4. 4.
    Silverberg SG, Kurman RJ: Tumors of the uterine corpus and gestational trophoblastic disease. Atlas of Tumor Pathology, 3rd series, Fascicle 3. Washington, DC: Armed Forces Institute of Pathology, 1992.Google Scholar
  5. 5.
    Kraus FT: High-risk and premalignant lesions of the endometrium. Am J Surg Pathol 1985; 9(Suppl): 31–40.Google Scholar
  6. 6.
    Welch WR, Scully RE: Precancerous lesions of the endometrium. Hum Pathol 1977;8:503–512.PubMedCrossRefGoogle Scholar
  7. 7.
    Ghamlian DL, Taylor HB: Endometrial hyperplasia in young women. Obstet Gynecol 1970;36: 659–660.Google Scholar
  8. 8.
    Lee KR, Scully RE: Complex endometrial hyperplasia and carcinoma in adolescents and young women 15 to 20 years of age: A report of 10 cases. IntJ Gynecol Pathol 1989;8:201–213.CrossRefGoogle Scholar
  9. 9.
    McBride JM: Pre-menopausal cystic hyperplasia and endometrial carcinoma. J Obstet Gynaecol Br Emp 1959;66:288–296.PubMedCrossRefGoogle Scholar
  10. 10.
    Gusberg SB, Kaplan AL: Precursors of corpus cancer. IV. Adenomatous hyperplasia as stage 0 carcinoma of the endometrium. Am J Obstet Gynecol 1963;87:662–677.PubMedGoogle Scholar
  11. 11.
    Hertig AT, Sommers SC: Genesis of endometrial carcinoma. I. Study of prior biopsies. Cancer 1949;2:946–956.PubMedCrossRefGoogle Scholar
  12. 12.
    Kurman RJ, Kaminski PF, Norris HJ: The behavior of endometrial hyperplasia. A long-term study of “untreated” hyperplasia in 170 patients. Cancer 1985;56:403–412.PubMedCrossRefGoogle Scholar
  13. 13.
    Tavassoli F, Kraus FT: Endometrial lesion in uteri resected for atypical endometrial hyperplasia. Am J Clin Pathol 1978;70:772–777.Google Scholar
  14. 14.
    Deligdisch L, Cohen CJ: Histologic correlates and virulence implications of endometrial carcinoma associated with adenomatous hyperplasia. Cancer 1985;56:1452.PubMedCrossRefGoogle Scholar
  15. 15.
    Buehl IA, Velhos KF, Carter JE, Huber CP: Carcinoma in situ of the endometrium. Am J Clin Pathol 1964;42:594–601.PubMedGoogle Scholar
  16. 16.
    Campbell PE, Barter RA: The significance of atypical hyperplasia. J Obstet Gynaecol Br Commonw 1961;68:668–672.PubMedCrossRefGoogle Scholar
  17. 17.
    Hertig AT, Sommers SC, Bengaloff H: Genesis of endometrial carcinoma. III. Carcinoma in situ. Cancer 1949;2:964–971.PubMedCrossRefGoogle Scholar
  18. 18.
    Winkler B, Alvarez S, Richart RM, Crum CP: Pitfalls in the diagnosis of endometrial neoplasia. Obstet Gynecol 1984;64:185–194.PubMedGoogle Scholar
  19. 19.
    Crum CP, Richart RM, Fenoglio CM: Adeno-acanthosis of the endometrium. A clinicopathologic study in premenopausal women. Am J Surg Pathol 1981;5:15.PubMedCrossRefGoogle Scholar
  20. 20.
    Hendrickson MR, Kempson RL: Endometrial epithelial metaplasias: Proliferations frequently misdiagnosed as adenocarcinoma. Report of 89 cases and proposed classification. Am J Surg Pathol 1980;4:525–542PubMedCrossRefGoogle Scholar
  21. 21.
    Blaustein A: Morular metaplasia misdiagnosed as adenoacanthoma in young women with polycystic ovarian disease. Am J Surg Pathol 1982; 6:223.PubMedCrossRefGoogle Scholar
  22. 22.
    Clement PB: Pathology of the uterine corpus. Hum Pathol 1991;22:776–791.PubMedCrossRefGoogle Scholar
  23. 23.
    Vellios F: Endometrial hyperplasia and carcinoma in situ. Gynecol Oncol 1974;2:152–161.PubMedCrossRefGoogle Scholar
  24. 24.
    Scully RE, Bonfiglio TA, Kurman RJ, Silverberg SG, Wilkinson EJ: International Histological Classification and Typing of Female Genital Tract Tumours. Berlin: Springer-Verlag, 1994.CrossRefGoogle Scholar
  25. 25.
    Hendrickson MR, Kempson RL: Surgical pathology of the uterine corpus (Major Problems in Pathology series). Volume 12. Philadelphia: W.B. Saunders, 1980.Google Scholar
  26. 26.
    Buckley CH, Fox H: Biopsy Pathology of the Endometrium. New York: Raven Press, 1989.Google Scholar
  27. 27.
    Kurman RJ, Norris HJ: Evaluation of criteria for distinguishing atypical endometrial hyperplasia from well-differentiated carcinoma. Cancer 1982;49:2547–2557.PubMedCrossRefGoogle Scholar
  28. 28.
    Gray LA, Robertson RW Jr, Christopherson WM: Atypical endometrial changes associated with carcinoma. Gynecol Oncol 1974;2:93–100.PubMedCrossRefGoogle Scholar
  29. 29.
    King A, Seraj IM, Wagner RJ: Stromal invasion in endometrial carcinoma. Am J Obstet Gynecol 1984;149:10–14.PubMedGoogle Scholar
  30. 30.
    Zaman SS, Mazur MT: Endometrial papillary syncytial change. A nonspecific alteration associated with active breakdown. Am J Clin Pathol 1993; 99:741–745.PubMedGoogle Scholar
  31. 31.
    Andersen WA, Taylor PT, Fechner RE, Pinkerton JAV: Endometrial metaplasia associated with endometrial carcinoma. Am J Obstet Gynecol 1987;157:597–604.PubMedGoogle Scholar
  32. 32.
    Kaku T, Tsukamoto N, Tsuruchi N, Sugihara K, Kamura T, et al: Endometrial metaplasia associated with endometrial carcinoma. Obstet Gynecol 1992;80:812–816.PubMedGoogle Scholar
  33. 33.
    Dutra F: Intraglandular morules of the endometrium. Am J Clin Pathol 1959;31:60–65.PubMedGoogle Scholar
  34. 34.
    Masterson R, Armstrong EM, More IAR: The cyclical variation in the percentage of ciliated cells in the normal human endometrium. J Reprod Fertil 1975;42:537–540.CrossRefGoogle Scholar
  35. 35.
    Rorat E, Wallach RC: Papillary metaplasia of the endometrium: Clinical and histopathologic considerations. Obstet Gynecol 1984;64:90S–92S.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1995

Authors and Affiliations

  • Michael T. Mazur
    • 1
  • Robert J. Kurman
    • 2
    • 3
  1. 1.Crouse Irving Memorial Hospital, Health Science CenterState University of New YorkSyracuseUSA
  2. 2.Departments of Gynecology and Obstetrics and PathologyThe Johns Hopkins HospitalBaltimoreUSA
  3. 3.The Johns Hopkins University School of MedicineBaltimoreUSA

Personalised recommendations